ColorChip Ltd. specializes in the development of integrated optical components and sub-systems tailored for networking and communication applications, primarily serving the Datacom and Telecom markets. Founded in 2001 and based in Yokneam, Israel, the company offers a range of products, including transceivers for high-speed Ethernet links, data center interconnections, and various optical networking applications. Its technology is rooted in Application Specific Photonic Integrated Circuits (ASPICs) and robust planar lightwave circuit (PLC) technology, enabling the creation of dense multi-lane photonic integrated circuits and other optical solutions. ColorChip's products also encompass PLC splitter chips and wafers for FTTX networks, as well as components for both analog and digital passive optical networks. With a focus on scalability and advanced manufacturing processes, ColorChip supports critical infrastructure in the telecommunications industry, particularly for data centers and enterprise networking.
ColorChip Ltd. specializes in the development of integrated optical components and sub-systems tailored for networking and communication applications, primarily serving the Datacom and Telecom markets. Founded in 2001 and based in Yokneam, Israel, the company offers a range of products, including transceivers for high-speed Ethernet links, data center interconnections, and various optical networking applications. Its technology is rooted in Application Specific Photonic Integrated Circuits (ASPICs) and robust planar lightwave circuit (PLC) technology, enabling the creation of dense multi-lane photonic integrated circuits and other optical solutions. ColorChip's products also encompass PLC splitter chips and wafers for FTTX networks, as well as components for both analog and digital passive optical networks. With a focus on scalability and advanced manufacturing processes, ColorChip supports critical infrastructure in the telecommunications industry, particularly for data centers and enterprise networking.
Panoratio Database Images GmbH, founded in 2003 and based in Munich, Germany, offers a Big Data as a Service platform tailored for B2B solution providers. The company's platform delivers big data analytics applications designed to assist consulting and managed services partners in managing extensive data volumes, ensuring accurate and unbiased information, and providing insights into organizational interdependencies. This enables users to identify leverage points for mitigating business risks and enhancing performance. Panoratio's development originated from research at the Siemens AG Artificial Intelligence / Machine Learning Laboratory, which aimed to address complex dataset analysis in gas turbine engine performance. The company’s flagship product, PANOsight, utilizes patented compression technology to maintain data integrity while reducing dataset size. Panoratio serves various industries, including insurance, pharmaceuticals, audit and financial services, marketing consulting, retail, and telecommunications, with over 50 clients, including notable companies such as AOK, AOL, and Vodafone.
Cappella, Inc., a Dover, Del.- and Galway, Ireland-based medical device company that is developing novel solutions for the treatment of Complex Coronary Artery Disease (CAD) and specifically bifurcation vascular disease. The company was founded in 2004 by Antonio Columbo, M.D., Chief of Invasive Cardiology at San Raffaele Hospital in Milan, Italy, and Ascher Shmulewitz, M.D., Ph.D., a cardiologist, medical device entrepreneur and founder of NeoVision, Xcardia and Labcoat Ltd., and established its European headquarters in Galway in 2005.
Varioptic SA provides adjustable lens solutions. Its products include variable focus liquid lenses, liquid lens for focus and astigmatism control, auto focus lens modules, microscope auto focus modules, liquid lens driver ICs, and liquid lens development kits. The company’s products are used in industrial, biometrics, medical, and consumer applications. It sells its products through distributors. The company was founded in 2002 and is based in Lyon, France. As of December 29, 2016, Varioptic SA operates as a subsidiary of Invenios France SAS.
Cappella, Inc., a Dover, Del.- and Galway, Ireland-based medical device company that is developing novel solutions for the treatment of Complex Coronary Artery Disease (CAD) and specifically bifurcation vascular disease. The company was founded in 2004 by Antonio Columbo, M.D., Chief of Invasive Cardiology at San Raffaele Hospital in Milan, Italy, and Ascher Shmulewitz, M.D., Ph.D., a cardiologist, medical device entrepreneur and founder of NeoVision, Xcardia and Labcoat Ltd., and established its European headquarters in Galway in 2005.
BiPar Sciences Inc. is a Brisbane, CA based developer of PARP inhibitors as cancer therapies. BiPar's key experimental product is BSI-201, currently in mid-stage trials for advanced breast cancer, ovarian cancer and other tumors. BiPar has raised around $60 million in VC funding, from firms like [Domain Associates](/financial-organization/domain-associates), [Canaan Partners](/financial-organization/canaan-partners-3), [Vulcan Capital](/financial-organization/vulcan-capital), [PolyTechnos Venture Partners](/financial-organization/polytechnos-venture-partners), [Asset Management Company](/financial-organization/asset-management), and [Quantum Technology Partners](/financial-organization/quantum-technology-partners). It also has raised venture debt from [Lighthouse Capital Partners](/financial-organization/lighthouse-capital-partners). On April 15th, 2009, French drug maker [Sanofi-Aventis S.A.](/organization/sanofi-aventis-2) announced it was acquiring BiPar Sciences for up to $500 million.
Nanotron Technologies GmbH, based in Berlin, Germany, specializes in embedded location platforms that provide location-awareness solutions for various industrial and consumer applications. Established in 1991, the company develops wireless products that combine high-speed data transmission with precise location information, achieving accuracy within one meter. Its flagship product, nanoLOC, integrates wireless communication and location capabilities in a single chip, ensuring robust signal strength and low energy consumption. The company’s offerings include real-time location systems, transceivers, collision avoidance solutions, and various applications for work safety, workflow management, and proximity authentication. Nanotron Technologies operates as a subsidiary of Inpixon GmbH and focuses on enhancing safety and productivity through innovative location-aware technologies.
NemeriX SA operates as a fabless semiconductor company that develops ultra-low-power, semiconductors, and software solutions for global positioning system and location-based service products. Its products include analog RF receivers, baseband, and indoor global positioning system integrates chips, as well as global positioning systems based integrated chipset. The company also offers OS support for WinCE, WinMobile, WinXP, LinuX, Symbian, and Nucleus; NeX, an extended ephemeris solution that enables mobile devices to acquire immediate positioning information in difficult garage scenarios and in harshest multi-path environments; SUPL client, which is inter-operated with several independent SUPL servers. In addition, it offers solutions to enable product integration, including evaluation boards, system software reference designs, user documentation, online support, and access to designers and global cadre of application engineers. The company’s product application areas include cellular phones, battery-powered wireless and handheld terminals, personal navigation devices, personal media players, and digital still cameras. It serves proximity-based marketing, social networking, gaming and financial authentication, navigation, tracking, and emergency markets. The company was founded in 2002 and is based in Manno, Switzerland. It has a design center in Cambridge, the United Kingdom; an applications center in Seoul, Korea; a technical center in Taipei, Taiwan; and sales offices in the United States, Europe, Taiwan, and Japan.
Nanotron Technologies GmbH, based in Berlin, Germany, specializes in embedded location platforms that provide location-awareness solutions for various industrial and consumer applications. Established in 1991, the company develops wireless products that combine high-speed data transmission with precise location information, achieving accuracy within one meter. Its flagship product, nanoLOC, integrates wireless communication and location capabilities in a single chip, ensuring robust signal strength and low energy consumption. The company’s offerings include real-time location systems, transceivers, collision avoidance solutions, and various applications for work safety, workflow management, and proximity authentication. Nanotron Technologies operates as a subsidiary of Inpixon GmbH and focuses on enhancing safety and productivity through innovative location-aware technologies.
Cappella, Inc., a Dover, Del.- and Galway, Ireland-based medical device company that is developing novel solutions for the treatment of Complex Coronary Artery Disease (CAD) and specifically bifurcation vascular disease. The company was founded in 2004 by Antonio Columbo, M.D., Chief of Invasive Cardiology at San Raffaele Hospital in Milan, Italy, and Ascher Shmulewitz, M.D., Ph.D., a cardiologist, medical device entrepreneur and founder of NeoVision, Xcardia and Labcoat Ltd., and established its European headquarters in Galway in 2005.
BiPar Sciences Inc. is a Brisbane, CA based developer of PARP inhibitors as cancer therapies. BiPar's key experimental product is BSI-201, currently in mid-stage trials for advanced breast cancer, ovarian cancer and other tumors. BiPar has raised around $60 million in VC funding, from firms like [Domain Associates](/financial-organization/domain-associates), [Canaan Partners](/financial-organization/canaan-partners-3), [Vulcan Capital](/financial-organization/vulcan-capital), [PolyTechnos Venture Partners](/financial-organization/polytechnos-venture-partners), [Asset Management Company](/financial-organization/asset-management), and [Quantum Technology Partners](/financial-organization/quantum-technology-partners). It also has raised venture debt from [Lighthouse Capital Partners](/financial-organization/lighthouse-capital-partners). On April 15th, 2009, French drug maker [Sanofi-Aventis S.A.](/organization/sanofi-aventis-2) announced it was acquiring BiPar Sciences for up to $500 million.
ColorChip Ltd. specializes in the development of integrated optical components and sub-systems tailored for networking and communication applications, primarily serving the Datacom and Telecom markets. Founded in 2001 and based in Yokneam, Israel, the company offers a range of products, including transceivers for high-speed Ethernet links, data center interconnections, and various optical networking applications. Its technology is rooted in Application Specific Photonic Integrated Circuits (ASPICs) and robust planar lightwave circuit (PLC) technology, enabling the creation of dense multi-lane photonic integrated circuits and other optical solutions. ColorChip's products also encompass PLC splitter chips and wafers for FTTX networks, as well as components for both analog and digital passive optical networks. With a focus on scalability and advanced manufacturing processes, ColorChip supports critical infrastructure in the telecommunications industry, particularly for data centers and enterprise networking.
Intelligent Medical Implants Ltd
Series B in 2006
IMI Intelligent Medical Implants develops and markets intelligent retinal implant systems for degenerative retinal disorders. The company offers The Intelligent Retinal Implant System, an adaptive visual prosthesis that bridges and replaces the defective information processing function of the real retina in patients with retinal degeneration. IMI Intelligent Medical Implants was founded in 2002 and is based in Zug, Switzerland.
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company based in Geneva, Switzerland, dedicated to the discovery and development of innovative small-molecule pharmaceutical products aimed at treating central nervous system (CNS) disorders. The company specializes in creating oral allosteric modulators that target G-protein coupled receptors, which are crucial for therapeutic interventions. Its leading programs include Dipraglurant, designed for treating levodopa-induced dyskinesia and dystonia in Parkinson’s disease, ADX71149 for epilepsy and other undisclosed CNS disorders, and a GABAB PAM aimed at addressing addiction. Addex Therapeutics has established a collaboration with Janssen Pharmaceuticals to advance the development of mGluR2PAM compounds for human health applications. Founded in 2002, the company has evolved its focus and pipeline based on a pioneering drug discovery platform that emphasizes allosteric modulation.
Innolume GmbH is a manufacturer of laser diodes and optoelectronic devices based in Dortmund, Germany. Established in 2002 and formerly known as NL-Nanosemiconductor GmbH, the company specializes in a wide range of products, including single-mode and broad-area laser diodes, comb lasers, and semiconductor optical amplifiers. Innolume's innovations include a novel comb laser light engine designed for short-reach optical interconnects, which utilizes economical wavelength-division multiplexing to enhance efficiency in computing systems. The company's products are utilized in various applications, such as Raman amplification, optical interconnects, and in the medical and industrial sectors. By providing fast product development and customization, Innolume aims to reduce costs associated with optical services, making them suitable for high-volume computing applications.
Varioptic SA provides adjustable lens solutions. Its products include variable focus liquid lenses, liquid lens for focus and astigmatism control, auto focus lens modules, microscope auto focus modules, liquid lens driver ICs, and liquid lens development kits. The company’s products are used in industrial, biometrics, medical, and consumer applications. It sells its products through distributors. The company was founded in 2002 and is based in Lyon, France. As of December 29, 2016, Varioptic SA operates as a subsidiary of Invenios France SAS.
ColorChip Ltd. specializes in the development of integrated optical components and sub-systems tailored for networking and communication applications, primarily serving the Datacom and Telecom markets. Founded in 2001 and based in Yokneam, Israel, the company offers a range of products, including transceivers for high-speed Ethernet links, data center interconnections, and various optical networking applications. Its technology is rooted in Application Specific Photonic Integrated Circuits (ASPICs) and robust planar lightwave circuit (PLC) technology, enabling the creation of dense multi-lane photonic integrated circuits and other optical solutions. ColorChip's products also encompass PLC splitter chips and wafers for FTTX networks, as well as components for both analog and digital passive optical networks. With a focus on scalability and advanced manufacturing processes, ColorChip supports critical infrastructure in the telecommunications industry, particularly for data centers and enterprise networking.
Panoratio Database Images GmbH, founded in 2003 and based in Munich, Germany, offers a Big Data as a Service platform tailored for B2B solution providers. The company's platform delivers big data analytics applications designed to assist consulting and managed services partners in managing extensive data volumes, ensuring accurate and unbiased information, and providing insights into organizational interdependencies. This enables users to identify leverage points for mitigating business risks and enhancing performance. Panoratio's development originated from research at the Siemens AG Artificial Intelligence / Machine Learning Laboratory, which aimed to address complex dataset analysis in gas turbine engine performance. The company’s flagship product, PANOsight, utilizes patented compression technology to maintain data integrity while reducing dataset size. Panoratio serves various industries, including insurance, pharmaceuticals, audit and financial services, marketing consulting, retail, and telecommunications, with over 50 clients, including notable companies such as AOK, AOL, and Vodafone.
NemeriX SA operates as a fabless semiconductor company that develops ultra-low-power, semiconductors, and software solutions for global positioning system and location-based service products. Its products include analog RF receivers, baseband, and indoor global positioning system integrates chips, as well as global positioning systems based integrated chipset. The company also offers OS support for WinCE, WinMobile, WinXP, LinuX, Symbian, and Nucleus; NeX, an extended ephemeris solution that enables mobile devices to acquire immediate positioning information in difficult garage scenarios and in harshest multi-path environments; SUPL client, which is inter-operated with several independent SUPL servers. In addition, it offers solutions to enable product integration, including evaluation boards, system software reference designs, user documentation, online support, and access to designers and global cadre of application engineers. The company’s product application areas include cellular phones, battery-powered wireless and handheld terminals, personal navigation devices, personal media players, and digital still cameras. It serves proximity-based marketing, social networking, gaming and financial authentication, navigation, tracking, and emergency markets. The company was founded in 2002 and is based in Manno, Switzerland. It has a design center in Cambridge, the United Kingdom; an applications center in Seoul, Korea; a technical center in Taipei, Taiwan; and sales offices in the United States, Europe, Taiwan, and Japan.
BiPar Sciences Inc. is a Brisbane, CA based developer of PARP inhibitors as cancer therapies. BiPar's key experimental product is BSI-201, currently in mid-stage trials for advanced breast cancer, ovarian cancer and other tumors. BiPar has raised around $60 million in VC funding, from firms like [Domain Associates](/financial-organization/domain-associates), [Canaan Partners](/financial-organization/canaan-partners-3), [Vulcan Capital](/financial-organization/vulcan-capital), [PolyTechnos Venture Partners](/financial-organization/polytechnos-venture-partners), [Asset Management Company](/financial-organization/asset-management), and [Quantum Technology Partners](/financial-organization/quantum-technology-partners). It also has raised venture debt from [Lighthouse Capital Partners](/financial-organization/lighthouse-capital-partners). On April 15th, 2009, French drug maker [Sanofi-Aventis S.A.](/organization/sanofi-aventis-2) announced it was acquiring BiPar Sciences for up to $500 million.
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company based in Geneva, Switzerland, dedicated to the discovery and development of innovative small-molecule pharmaceutical products aimed at treating central nervous system (CNS) disorders. The company specializes in creating oral allosteric modulators that target G-protein coupled receptors, which are crucial for therapeutic interventions. Its leading programs include Dipraglurant, designed for treating levodopa-induced dyskinesia and dystonia in Parkinson’s disease, ADX71149 for epilepsy and other undisclosed CNS disorders, and a GABAB PAM aimed at addressing addiction. Addex Therapeutics has established a collaboration with Janssen Pharmaceuticals to advance the development of mGluR2PAM compounds for human health applications. Founded in 2002, the company has evolved its focus and pipeline based on a pioneering drug discovery platform that emphasizes allosteric modulation.
Varioptic SA provides adjustable lens solutions. Its products include variable focus liquid lenses, liquid lens for focus and astigmatism control, auto focus lens modules, microscope auto focus modules, liquid lens driver ICs, and liquid lens development kits. The company’s products are used in industrial, biometrics, medical, and consumer applications. It sells its products through distributors. The company was founded in 2002 and is based in Lyon, France. As of December 29, 2016, Varioptic SA operates as a subsidiary of Invenios France SAS.
Innolume GmbH is a manufacturer of laser diodes and optoelectronic devices based in Dortmund, Germany. Established in 2002 and formerly known as NL-Nanosemiconductor GmbH, the company specializes in a wide range of products, including single-mode and broad-area laser diodes, comb lasers, and semiconductor optical amplifiers. Innolume's innovations include a novel comb laser light engine designed for short-reach optical interconnects, which utilizes economical wavelength-division multiplexing to enhance efficiency in computing systems. The company's products are utilized in various applications, such as Raman amplification, optical interconnects, and in the medical and industrial sectors. By providing fast product development and customization, Innolume aims to reduce costs associated with optical services, making them suitable for high-volume computing applications.
Plastic Logic Germany leads the way in developing, manufacturing and commercializing flexible displays. The company has successfully industrialized the manufacturing process in its facility, the world’s first commercial, volume, organic electronics factory. Using a stable and proven licensed technology transistor platform, the company manufactures a range of high-quality, flexible plastic displays. These shatterproof, daylight-readable displays are ultra-thin, ultra-lightweight and very low-power, offering huge advantages over conventional screens as they are extremely robust with proven lifetimes. Plastic Logic Germany also runs an open pilot line for flexible electronics. Third party companies are invited to benefit from the company’s years of experience in the industrialization and manufacture of flexible electronics. Plastic Logic Germany’s customers include OEMs and electronics manufacturers for signage and logistics, mobile electronic devices, smart-cards, wearables and more. For more information, please visit www.plasticlogic.com.
- Jerini was founded in 1994 as a spin-off from the Medical Faculty (Charité) Humboldt University Berlin to commercialize the SPOT™ technology. The evolving SPOT™ platform was marketed as fee for service projects to pharmaceutical and biotech companies (1995 to 1999). The revenues generated supported the expansion of the company and its technology development. At this stage no venture capital was raised. Due to the expanding applications of its technology platform in drug discovery and proteomics Jerini began its transformation into a drug discovery company. - To support and accelerate the drug discovery transition Jerini raised Euro 4.6 million in January 2000 in a first financing round that included local investors IBB-Bet. GmbH, bmp AG and tbg. In 2001 the company converted to an AG (joint-stock company) and closed its second, private financing round raising Euro 20 million in November 2001. The investors in this round included an international group represented by TVM, 3i, Polytechnos and Sanders Morris and Harris. - In 2000 Jerini started creating the medicinal chemistry platform PepMed™ focusing on the identification of peptide lead structures addressing difficult protein targets and their subsequent systematic transformation into drug-like molecules. - In December 2001 Jerini started its first clinical trials with Icatibant, a peptidomimetic bradykinin receptor antagonist for the indication defined as end-stage liver cirrhosis.
ColorChip Ltd. specializes in the development of integrated optical components and sub-systems tailored for networking and communication applications, primarily serving the Datacom and Telecom markets. Founded in 2001 and based in Yokneam, Israel, the company offers a range of products, including transceivers for high-speed Ethernet links, data center interconnections, and various optical networking applications. Its technology is rooted in Application Specific Photonic Integrated Circuits (ASPICs) and robust planar lightwave circuit (PLC) technology, enabling the creation of dense multi-lane photonic integrated circuits and other optical solutions. ColorChip's products also encompass PLC splitter chips and wafers for FTTX networks, as well as components for both analog and digital passive optical networks. With a focus on scalability and advanced manufacturing processes, ColorChip supports critical infrastructure in the telecommunications industry, particularly for data centers and enterprise networking.
The Patent & License Exchange ("pl-x.com") is the first e-business marketplace for intellectual property rights - patents, copyrights, trademarks, trade secrets and know how. By applying financial market technology and discipline to the intellectual property market, pl-x.com is bringing the 200-year-old system of intellectual property exchange into the 21st century and creating the safest marketplace in the world.